CLINICAL_TRIALS
trial_result
· 2021-04-06
Clinical Trial Update: Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial [Phase 2, Phase 3]
Summary
Adaptive trial evaluating selepressin for sepsis-induced shock was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Septic Shock | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-04-06